Format

Send to

Choose Destination
Drugs. 2016 Sep;76(14):1349-64. doi: 10.1007/s40265-016-0629-5.

Androgenetic Alopecia: An Update of Treatment Options.

Author information

1
Department of Dermatology, Universidade de São Paulo, São Paulo, SP, Brazil. yannakfs@gmail.com.
2
Department of Dermatology, Hospital do Servidor Publico Municipal de São Paulo, São Paulo, SP, Brazil. yannakfs@gmail.com.
3
, 1364, Oscar Freire Street, São Paulo, SP, 05409-010, Brazil. yannakfs@gmail.com.
4
Department of Dermatology, Universidade Federal do Mato Grosso do Sul, Campo Grande, MS, Brazil.
5
Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.

Abstract

Androgenetic alopecia (AGA) is characterized by a non-scarring progressive miniaturization of the hair follicle in predisposed men and women with a pattern distribution. Although AGA is a very prevalent condition, approved therapeutic options are limited. This article discusses the current treatment alternatives including their efficacy, safety profile, and quality of evidence. Finasteride and minoxidil for male androgenetic alopecia and minoxidil for female androgenetic alopecia still are the therapeutic options with the highest level evidence. The role of antiandrogens for female patients, the importance of adjuvant therapies, as well as new drugs and procedures are also addressed.

PMID:
27554257
DOI:
10.1007/s40265-016-0629-5
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center